LOGOLOGOLOGOLOGO
  • About us
    • What we do
    • Who we are
      • Governance
      • Staff
      • Vacancies
  • Members
    • EuropaBio Members
    • About Membership
  • How we work
    • Healthcare Biotechnology Council
      • Patient BioForum
      • Study – Impact of the EU’s General Pharmaceutical Legislation
    • Industrial Biotechnology Council
      • EFIB
      • Microorganisms
    • National Associations Council
    • SME Platform
    • Biomanufacturing Platform
      • Biotechnology in our Lives
  • Activities
    • 25 Years of Innovation
    • The EU Biotech Act
    • European Biotech Week
    • EU Projects
      • PRIMED Project
      • APROVALS Project
  • News & Events
    • News
    • Events
  • Library
Become a member
✕

EuropaBio AGM 2025: Association Chair, Executive Committee and Board announced

26/06/2025

PRESS RELEASE

Brussels, 26 June 2025

EuropaBio’s 2025 Annual General Meeting (AGM), held on the 26th of June, welcomed a new Association Chair, Markus Stämpfli, representing CSL Behring. It also confirmed a new Executive Committee and Board members, plus new members from across biotechnology ecosystems and international locations.

EuropaBio welcomes the new Executive Committee & Board representatives, who will bring leadership from across their respective sectors within biotechnology, and will prove invaluable in guiding the association going forward.

  • Markus Stämpfli representing CSL Behring, elected as Chair of the Association
  • Ion Arocena representing AseBio, elected as Treasurer
  • Ricardo Gent representing Deutsche Industrievereinigung Biotechnologie (DIB), new Chair of the National Associations Council
  • Jessica Martinsson representing SwedenBio, new Chair of the SME Platform
  • Ana María Bravo Angel representing IFF, renewed as Chair of the Industrial Biotechnology Council
  • Giovanni Colombo representing dsm-firmenich, elected as new Board Member
  • Philippe Ghyssels representing Ipsen, elected as new Board Member

Additionally, 14 new member companies and associations were confirmed during the AGM, expanding the diverse set of members contributing to the biotechnology ecosystem in Europe. EuropaBio welcomes Adisseo, Bio Base Europe Pilot Plant, Bronkhorst High-Tech, Dansk Biotek, Enduro Genetics, Hawkwood Biotech, KINTIGA, NIBRT, OM Pharma, Sartorius, ShakeUp Factory, Syneos, Synonym and Vintura.

Markus Stämpfli, the new Chair of EuropaBio added “As a leading biotechnology company, in CSL Behring we are driven by our ceaseless commitment to patients through innovative therapies and sustained focus on improving lives. EuropaBio’s work to strengthening the EU policy landscape is essential to materialize a high performing and resilient biotech ecosystem in Europe for today’s and future European generations. We will work across sectors and with all stakeholders to shape the legislative, regulatory, economic, and societal conditions needed to turn ambition into action.”

EuropaBio AGM 2025: Association Chair, Executive Committee and Board announced


Download
Share
Adrian Lincoln
Adrian Lincoln

Related posts

11/07/2025

Industrial Decarbonisation Accelerator Act – EuropaBio Position


Read more
07/07/2025

EuropaBio Position on the Critical Medicines Act


Read more
03/07/2025

Life Sciences Strategy Embraces Biotech for Global Impact


Read more

Important links

  • Industrial Decarbonisation Accelerator Act – EuropaBio Position
  • EuropaBio Position on the Critical Medicines Act

Categories in our Newsroom

EBIO-white

EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 5000 biotech companies, 4600 out of them are SMEs.

Contact us

Extra links

Members
Staff
Privacy policy
Legal & cookies
Events
Newsroom

Become a member

Media pack

© 2025 Europabio. All Rights Reserved. Designed by EYAS
Become a member

Algal Omega 3

Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.

Cheese

Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.

Clothes

Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

Vitamin B2

The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

Detergents

Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

Insulin

Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.